Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients

Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, de...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hideta, Ouchi, Gen, Miyagi, Kazuya, Higure, Yuuri, Otsuki, Mariko, Nishiyama, Naoya, Kinjo, Takeshi, Nakamatsu, Masashi, Tateyama, Masao, Kukita, Ichiro, Fujita, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941852/
https://www.ncbi.nlm.nih.gov/pubmed/33534775
http://dx.doi.org/10.4269/ajtmh.20-1507
Descripción
Sumario:Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, despite high mortality. Here, we discuss two cases of spontaneous iliopsoas hematoma (IPH) likely caused by anticoagulants during the clinical course of COVID-19. We also explored published case reports to identify clinical characteristics of IPH in COVID-19 patients. The use of anticoagulants may increase the risk of lethal IPH among COVID-19 patients becsuse of scarce data on optimal dosage and adequate monitoring of anticoagulant effects. Rapid diagnosis and timely intervention are crucial to ensure good patient outcomes.

Ejemplares similares